42,364 resources
By Version
By Realm
Start Prev Rows 33200 - 33400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm |
---|---|---|---|---|---|---|---|---|
de.basisprofil.r4 | R4 | ValueSet/AufnahmegrundDritteStelleVS | AufnahmegrundDritteStelle ValueSet | active | 2025-06 | |||
de.basisprofil.r4 | R4 | ValueSet/AufnahmegrundVierteStelleVS | Aufnahmegrund Vierte Stelle ValueSet | active | 2025-06 | |||
hl7.fhir.au.base | R4 | ValueSet/au-timezone | AU Time Zone | trial-use | 1 | 2025-06 | au | |
fhir.ca-bc.client | R4 | ValueSet/bc-address-validation-value-set | BC Address Validation Value Set | active | 2025-02 | us | ||
fhir.ca-bc.client | R4 | ValueSet/bc-contact-point-system-value-set | BC Contact Point System Value Set | active | 2025-02 | us | ||
fhir.ca-bc.client | R4 | ValueSet/bc-contact-point-use-value-set | BC Contact Point Use Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-expertise-value-set | BC Expertise Value Set | active | 2025-02 | us | ||
fhir.ca-bc.client | R4 | ValueSet/bc-identifier-status-value-set | BC Identifier Status Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-language-value-set | BC Language Value Set | active | 2025-02 | us | ||
fhir.ca-bc.client | R4 | ValueSet/bc-merge-status-value-set | BC Merge Status Value Set | active | 2025-02 | us | ||
fhir.ca-bc.client | R4 | ValueSet/bc-name-use-value-set | BC Name Use value set. | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-organization-role-value-set | BC Organization Role Code Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-practitioner-role-value-set | BC Practitioner Role Code Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-address-validation-status-value-set | BC Address Validation Status Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-communication-purpose-value-set | BC Communication Purpose Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-end-reason-value-set | BC End Reason Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-relationship-type-value-set | BC Relationship Type Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-license-status-class-value-set | BC License Status Class Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-license-status-reason-value-set | BC License Status Reason Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-license-status-value-set | BC License Status Value Set | active | 2025-02 | us | ||
fhir.ca-bc.provider | R4 | ValueSet/bc-qualification-value-set | BC Practitioner Qualification Value Set | active | 2025-02 | us | ||
ch.fhir.ig.ch-elm | R4 | ValueSet/bfs-country-codes | BFS Verzeichnis der Staaten und Gebiete | active | 2024-05 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-20-encounterclass | BFS Medizinische Statistik - 20 1.3.V01 - Behandlungsart / Type de prise en charge / Genere di trattamento | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-29-dischargeencounter | BFS Medizinische Statistik - 29 1.5.V04 - Behandlung nach Austritt / Prise en charge après la sortie / Trattamento dopo l’uscita | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-18-admittype | BFS Medizinische Statistik - 18 1.2.V03 - Eintrittsart / Mode d’admission / Genere di ricovero | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-21-encountertype | BFS Medizinische Statistik - 21 1.3.V02 - Klasse / Classe / Classe | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-17-admitsource | BFS Medizinische Statistik - 17 1.2.V02 - Aufenthaltsort vor dem Eintritt / Séjour avant l’admission / Luogo di soggiorno prima dell’ammissione | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-19-admitrole | BFS Medizinische Statistik - 19 1.2.V04 - Einweisende Instanz / Décision d’envoi / Istanza ricoverante | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-27-dischargedecision | BFS Medizinische Statistik - 27 1.5.V02 - Entscheid für Austritt / Décision de sortie / Décisione dell’uscita | active | 2019-01 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/bfs-medstats-28-dischargedestination | BFS Medizinische Statistik - 28 1.5.V03 - Aufenthalt nach Austritt / Séjour après la sortie / Destinazione dopo l’uscita | active | 2019-01 | ch | ||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.5.1--20200901000000 | BMIScoreCodelijst | active | nl | |||
hl7.fhir.us.bser | R4 | ValueSet/TaskBusinessStatusVS | Task Business Status VS | draft | 2025-04 | us | ||
hl7.fhir.uv.genomics-reporting | R4 | ValueSet/genomic-study-change-type-vs | Genomic Study Change Type ValueSet | trial-use | 2 | cg | 2025-06 | uv |
hl7.fhir.uv.genomics-reporting | R4 | ValueSet/genomic-study-data-format-vs | Genomic Study Data Format ValueSet | trial-use | 2 | cg | 2025-06 | uv |
hl7.fhir.uv.genomics-reporting | R4 | ValueSet/genomic-study-method-type-vs | Genomic Study Method Type ValueSet | trial-use | 2 | cg | 2025-06 | uv |
hl7.fhir.uv.genomics-reporting | R4 | ValueSet/genomic-study-status-vs | Genomic Study Status ValueSet | trial-use | 2 | cg | 2025-06 | uv |
hl7.fhir.uv.genomics-reporting | R4 | ValueSet/genomic-study-type-vs | Genomic Study Type ValueSet | informative | cg | 2025-06 | uv | |
hl7.fhir.be.pss | R4 | ValueSet/BacterialCodes | Bacterial Codes | active | 2025-07 | be | ||
hl7.terminology | R5 | ValueSet/list-order | List Order Codes | active | fhir | 2024-04 | uv | |
hl7.fhir.be.mycarenet | R4 | ValueSet/be-vs-basic-laterality | Basic Laterality | trial-use | 1 | fhir | 2025-06 | be |
hl7.fhir.be.terminology | R4 | ValueSet/be-vs-basic-laterality | Basic Laterality | trial-use | 1 | fhir | 2025-02 | be |
hl7.fhir.be.terminology | R4 | ValueSet/be-vs-gender-at-birth | List of possible genders at birth in Belgium | active | 2024-08 | be | ||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.2.2.2--20200901000000 | BehandelBesluitCodelijst | active | nl | |||
de.gematik.isik | R4 | ValueSet/ISiKBehandlungsergebnisReha | ISiKBehandlungsergebnisRehaVS | active | 2025-06 | de | ||
hl7.fhir.uv.crmi | R4 | ValueSet/crmi-release-experimental-behavior | CRMI Release Experimental Behavior | trial-use | 2 | cds | 2025-08 | uv |
hl7.fhir.uv.crmi | R4 | ValueSet/crmi-release-version-behavior | CRMI Release Version Behavior | trial-use | 2 | cds | 2025-08 | uv |
hl7.fhir.us.davinci-drug-formulary | R4 | ValueSet/BenefitCostTypeVS | Benefit type of cost | trial-use | phx | 2025-02 | us | |
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.13.2--20200901000000 | BenenCodelijst | active | nl | |||
de.gematik.isik | R4 | ValueSet/ISiKBesondereBehandlungsformReha | ISiKBesondereBehandlungsformRehaVS | active | 2025-06 | de | ||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20200901000000 | BestemmingCodelijst | active | nl | |||
hl7.terminology | R5 | ValueSet/v3-BiliaryRoute | BiliaryRoute | active | 2014-03 | uv | ||
fhir.giis | R4 | ValueSet/BirthplaceVS | Birthplace | draft | 2025-07 | us | ||
hl7.fhir.be.core-clinical | R4 | ValueSet/be-vs-bodysite | Body Site | active | 1 | 2021-01 | be | |
ehealthplatform.be.r4.federalprofiles | R4 | ValueSet/be-vs-bodysite | Body Site | active | 2021-01 | |||
hl7.fhir.eu.base-r5 | R5 | ValueSet/siteLaterality-eu | Body Structure Laterality | draft | 2 | 2025-08 | eu | |
hl7.fhir.eu.base | R4 | ValueSet/siteLaterality-eu | Body Structure Laterality | draft | 2 | 2025-08 | eu | |
hl7.fhir.uv.lab-report | R4 | ValueSet/laterality-uv-lab | Body Structure Laterality | trial-use | 2 | oo | 2025-01 | uv |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-laterality-eu-lab | Body Structure Laterality | trial-use | 2 | 2025-07 | eu | |
hl7.fhir.cz.core | R4 | ValueSet/cz-laterality-lab | Body Structure Laterality | trial-use | 2 | 2025-08 | cz | |
hl7.fhir.eu.base-r5 | R5 | ValueSet/siteQualifier-eu | Body Structure Qualifier | draft | 2 | 2025-08 | eu | |
hl7.fhir.eu.base | R4 | ValueSet/siteQualifier-eu | Body Structure Qualifier | draft | 2 | 2025-08 | eu | |
hl7.fhir.uv.lab-report | R4 | ValueSet/siteQualifier-uv-lab | Body Structure Qualifier | trial-use | 2 | oo | 2025-01 | uv |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-siteQualifier-eu-lab | Body Structure Qualifier | trial-use | 2 | 2025-07 | eu | |
hl7.fhir.cz.core | R4 | ValueSet/cz-sitequalifier-vs | Body Structure Qualifier | draft | 2025-08 | cz | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | ValueSet/vs-body-positioning-snomed | Body Positioning SNOMED CT | draft | 2022-09 | uv | ||
hl7.fhir.be.terminology | R4 | ValueSet/be-vspopulationscreening-body-site-location | PopulationScreening Body Site Value Set | active | 1 | 2024-06 | be | |
hl7.terminology | R5 | ValueSet/v3-BodySurfaceRoute | BodySurfaceRoute | active | 2014-03 | uv | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1237.18 | Medication Prescribable Brand Name | active | 2021-06 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.88.12.80.16 | Medication Brand Name | active | 2024-06 | us | ||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20200901000000 | BrandwondSoortCodelijst | active | nl | |||
hl7.fhir.us.breast-radiology | R4 | ValueSet/BreastAssessmentCategoryVS | Breast Assessment Category ValueSet | active | 2022-12 | us | ||
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1560-breast-body-landmark | RDE1560 Breast body landmark | draft | 2022-12 | us | ||
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1557-side | RDE1557 Side | draft | 2022-12 | us | ||
hl7.fhir.us.directory-query | R4 | ValueSet/HealthcareServiceCategoryVS | Healthcare Service Category Value Set | active | 2022-12 | us | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/HealthcareServiceCategoryVS | Healthcare Service CategoryVS | trial-use | fm | 2025-02 | us | |
hl7.fhir.us.ndh | R4 | ValueSet/HealthcareServiceCategoryVS | Healthcare Service Category Value Set | trial-use | pa | 2025-07 | us | |
signal.core.r4 | R4 | ValueSet/signal-healthcare-service-category | Signal Healthcare Service Category | draft | 1 | pa | us | |
hl7.terminology | R5 | ValueSet/v3-EmergencyMedicalServiceProviderHIPAA | EmergencyMedicalServiceProviderHIPAA | retired | 2014-03 | uv | ||
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/opioid-treatment-assessment-procedure | Opioid treatment assessment procedure | active | 2023-05 | us | ||
ch.fhir.ig.ch-lab-order | R4 | ValueSet/clinical-focus-vitamin-d | Vitamin D all possible clinical contexts for test | active | 2019-12 | ch | ||
ch.fhir.ig.ch-lab-order | R4 | ValueSet/reasons-for-order | All Valid Reasons for Ordering a Lab Service | active | 2019-12 | ch | ||
hl7.fhir.uv.order-catalog | R5 | ValueSet/example-clinical-focus | All possible clinical contexts for any lab test | trial-use | 2 | oo | 2019-12 | uv |
hl7.fhir.uv.order-catalog | R5 | ValueSet/example-reasons-for-order | All Valid Reasons for Ordering a Lab Service | trial-use | 2 | oo | 2019-12 | uv |
hl7.fhir.nl.zorgviewer | R3 | ValueSet/bronsysteem-zorgaanbieder | Bronsysteem Zorgaanbieder | active | 2025-08 | nl | ||
hl7.terminology | R5 | ValueSet/v3-BuccalMucosaRoute | BuccalMucosaRoute | active | 2014-03 | uv | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance | active | 2024-06 | us | ||
hl7.fhir.us.mcode | R4 | ValueSet/mcode-lymphoma-stage-bulky-modifier-vs | Lymphoma Stage Bulky Modifier Value Set | active | cic | 2025-02 | us | |
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.9.1--20200901000000 | BurgerlijkeStaatCodelijst | active | nl | |||
hl7.fhir.us.vdor | R4 | ValueSet/vdor-bystanders-present-vs | VDOR Bystander(s) Present | informative | pher | 2025-06 | us | |
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.6--20200901000000 | VerrichtingTypeCBVCodelijst | active | nl | |||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.88.12.3221.8.11 | Medication Product Form | active | 2024-06 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test | active | 2025-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test | active | 2022-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test | active | 2025-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.152 | Body Temperature | active | 2025-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.159 | Body Weight | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1104.10 | Medicare FFS Payer | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1104.12 | Medicare Advantage Payer | active | 2023-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.666.5.2363 | Creatinine Lab Test | active | 2025-02 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry | active | 2023-02 | us | ||
hl7.fhir.uv.tools | R5 | ValueSet/CDSActionType | CDSActionType Codes ValueSet | informative | 1 | fhir | 2025-08 | uv |
hl7.fhir.uv.tools | R5 | ValueSet/CDSIndicator | CDSIndicator Codes ValueSet | informative | 1 | fhir | 2025-08 | uv |
hl7.fhir.uv.tools | R5 | ValueSet/CDSLinkType | CDSLinkType Codes ValueSet | informative | 1 | fhir | 2025-08 | uv |
hl7.fhir.uv.tools | R5 | ValueSet/CDSSelectionBehavior | CDSSelectionBehavior Codes ValueSet | informative | 1 | fhir | 2025-08 | uv |
ch.fhir.ig.ch-term | R4 | ValueSet/CHAllergyIntoleranceValueSet | CH AllergyIntolerance | active | 2025-05 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/CHAllergyIntoleranceConditionValueSet | CH AllergyIntolerance Condition | active | 2025-05 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/CHAllergyIntoleranceReactionManifestationValueSet | CH AllergyIntolerance Reaction Manifestation | active | 2025-05 | ch | ||
ch.fhir.ig.ch-term | R4 | ValueSet/CHAllergyIntoleranceReactionSubstanceValueSet | CH AllergyIntolerance Reaction Substance | active | 2025-05 | ch | ||
ch.fhir.ig.ch-ig | R4 | ValueSet/ch-ig-example-sct | CH IG Example SNOMED CT | draft | 2025-06 | ch | ||
ch.fhir.ig.ch-ig | R4 | ValueSet/ch-ig-example-translation | CH IG Example Translation | draft | 2025-06 | ch | ||
ch.fhir.ig.ch-ig | R4 | ValueSet/ch-ig-example | CH IG Example | draft | 2025-06 | ch | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.36 | All Metastatic Sites | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.43 | Breast Cancer | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.44 | Breast Cancer | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.15 | All Metastatic Sites | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.35 | All Metastatic Sites | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.39 | Locoregional Breast Cancer | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.38 | Locoregional Breast Cancer | active | 2023-10 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.37 | Locoregional Breast Cancer | active | 2023-10 | us | ||
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTGFECMSPOS | PCT GFE CMS Place of Service Value Set | trial-use | fm | 2025-08 | us | |
signal.core.r4 | R4 | ValueSet/place-of-service | Place Of Service | draft | 1 | pa | us | |
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.17.2.4--20200901000000 | AfdelingSpecialismeCodelijst | active | nl | |||
ch.fhir.ig.ch-crl | R4 | ValueSet/nkrs-cogallstaging | NKRS - COG ALL Staging | active | 2022-02 | ch | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure | active | 2021-03 | us | ||
hl7.fhir.us.davinci-pct | R4 | ValueSet/USClaimMedicalProductOrServiceCodes | Claim Medical Product or Service Value Set | trial-use | fm | 2025-08 | us | |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTGFEItemCptHcpcsVS | PCT GFE Item CPT - HCPCS Value Set | trial-use | fm | 2025-08 | us | |
hl7.terminology | R5 | ValueSet/cpt-modifiers | AMA CPT Modifier Codes | active | vocab | 2023-08 | uv | |
hl7.fhir.us.icsr-ae-reporting | R4 | ValueSet/COVID19VaccineCodeVS | COVID-19 Vaccine Codes | draft | 2023-08 | us | ||
hl7.fhir.us.registry-protocols | R4 | ValueSet/CardiacCTA | CTA Heart and Coronary arteries | active | cic | 2023-11 | us | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.3.88.12.80.22 | CVX Vaccines Administered Complete Set | active | 2024-06 | us | ||
hl7.fhir.us.icsr-ae-reporting | R4 | ValueSet/VaccineCodeVS | Vaccine Codes | draft | 2023-08 | us | ||
hl7.fhir.us.icsr-ae-reporting | R4 | ValueSet/InfluenzaVaccineCodeVS | Influenza Vaccine Codes | draft | 2023-08 | us | ||
hl7.fhir.us.breast-radiology | R4 | ValueSet/CalcificationDistributionVS | CalcificationDistribution ValueSet | active | 2022-12 | us | ||
hl7.eu.fhir.idea4rc | R4 | ValueSet/vs-calcest-eu-i4rc | Calculated|Estimated | draft | 2025-07 | eu | ||
hl7.eu.fhir.pcsp | R4 | ValueSet/vs-calcest-eu-pcsp | Calculated|Estimated | draft | 2025-08 | eu | ||
hl7.fhirpath | R4 | ValueSet/calendar-units | Calendar Duration Units ValueSet | active | 2024-02 | uv | ||
hl7.fhir.cl.minsal.nid | R4 | ValueSet/VScalificacionPrevisional | Calificación Previsional | active | 2023-01 | cl | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1189 | California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative]) | active | 2023-06 | us | ||
hl7.fhir.cl.clcore | R4 | ValueSet/VSNombreCampana | Campañas de Vacunación | active | 2022-06 | cl | ||
hl7.fhir.cl.corecl | R4 | ValueSet/VSNombreCampana | Campañas de Vacunación | active | 2022-06 | cl | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.16 | All Metastatic Sites | active | 2023-10 | us | ||
hl7.fhir.be.pss | R4 | ValueSet/CandidaCodes | Candida Codes | active | 2025-07 | be | ||
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/cannabinoid-urine-drug-screening-tests | Cannabinoid class urine drug screening | active | 2023-05 | us | ||
hl7.terminology | R5 | ValueSet/v3-MedicationCap | MedicationCap | active | 2014-03 | uv | ||
ca.on.oh.mha-pds | R4 | ValueSet/Valueset.ca-on-mha-CitizenshipStatus | Citizenship Status | active | 2022-08 | ca | ||
hl7.fhir.us.registry-protocols | R4 | ValueSet/CardiacCTAResults | Cardiac CTA Results | active | cic | 2023-11 | us | |
hl7.fhir.us.registry-protocols | R4 | ValueSet/CardiacInstabilityType | Cardiac Instability Type | active | cic | 2023-11 | us | |
hl7.fhir.be.terminology | R4 | ValueSet/be-vs-care-location | BeVSCareLocation | active | 2021-01 | be | ||
hl7.fhir.be.vaccination | R4 | ValueSet/be-vs-care-location | BeVSCareLocation | active | 1 | 2025-03 | be | |
ehealthplatform.be.r4.federalprofiles | R4 | ValueSet/be-vs-care-location | Care Location Value Set | active | 2021-01 | |||
hl7.fhir.sami.core | R4 | ValueSet/Admission_priority | Prioridade de admissão | active | 2022-02 | sami | ||
hl7.terminology | R5 | ValueSet/v3-ActAdjudicationGroupCode | ActAdjudicationGroupCode | active | 2014-03 | uv | ||
hl7.fhir.uv.rfi-ig | R5 | ValueSet/rfi-category-subcategory | RFICategoryAndSubcategory | draft | 2025-06 | uv | ||
hl7.fhir.us.pco | R4 | ValueSet/pco-categories | Person-Centered Categories | draft | 2 | pc | 2025-08 | us |
hl7.fhir.us.directory-query | R4 | ValueSet/OrgAliasTypeVS | Organization Alias Typ Value Sete | active | 2022-12 | us | ||
hl7.fhir.us.ndh | R4 | ValueSet/OrgAliasTypeVS | Organization Alias Type Value Sete | trial-use | pa | 2025-07 | us | |
hl7.fhir.us.directory-query | R4 | ValueSet/InsurancePlanTypeVS | Insurance Plan Type Value Set | active | 2022-12 | us | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/InsurancePlanTypeVS | Insurance Plan TypeVS | trial-use | fm | 2025-02 | us | |
hl7.fhir.us.directory-query | R4 | ValueSet/OrgTypeVS | Organization Type Value Set | active | 2022-12 | us | ||
hl7.fhir.us.davinci-pdex | R4 | ValueSet/OrgTypeVS | Organization Type VS | informative | fm | 2025-06 | us | |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/OrgTypeVS | Organization Type VS | trial-use | fm | 2025-02 | us | |
hl7.fhir.us.ndh | R4 | ValueSet/OrgTypeVS | Organization Type Value Set | trial-use | pa | 2025-07 | us | |
hl7.fhir.uv.smart-app-launch | R4 | ValueSet/user-access-category | User Access Category Value Set | active | fhir | 2023-03 | uv | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | ValueSet/m11-amendment-scope-enrollment-vs | Study Amendment Scope Enrollment Value Set | trial-use | 2 | brr | 2025-07 | uv |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTBenefitBalanceCategoryVS | PCT benefitBalance.category codes | trial-use | fm | 2025-08 | us | |
hl7.eu.fhir.idea4rc | R4 | ValueSet/vs-surgicalProcedureCategory-eu-i4rc | Surgical Procedure Category | active | 2025-07 | eu | ||
hl7.fhir.be.problem | R4 | ValueSet/ProblemCategoryVS | Problem Category Value Set | active | 2025-05 | be | ||
hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/codexrt-radiotherapy-category-vs | Radiotherapy Category Code Max Value Set | active | cgp | 2025-02 | us | |
hl7.fhir.au.ereq | R4 | ValueSet/au-erequesting-communicationrequest-patientcategory | AU eRequesting CommunicationRequest Patient Category | draft | 0 | 2025-02 | au | |
hl7.fhir.cl.minsal.eis | R4 | ValueSet/VSUCursoAprobado | Ultimo Curso Aprobado | active | 2022-01 | cl | ||
hl7.fhir.us.registry-protocols | R4 | ValueSet/IntraAndPostEvents | Cath PCI qualified list of Events | active | cic | 2023-11 | us | |
hl7.fhir.be.allergy | R4 | ValueSet/be-causativeagent | BeCausativeAgent | active | 1 | 2025-07 | be | |
hl7.fhir.uv.order-catalog | R5 | ValueSet/example-normal-contexts-vitamin-d | Contextes de remboursement du dosage de la vitamine D | trial-use | 2 | oo | 2019-12 | uv |
hl7.terminology | R5 | ValueSet/v3-CecostomyRoute | CecostomyRoute | active | 2014-03 | uv | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1196.4502 | Ceftriaxone all code types | active | 2024-05 | us | ||
hl7se.fhir.base | R4 | ValueSet/SEBaseHOSPLegitimationsYrkeVS | ValueSet for certification occupation from HOSP | active | 2025-06 | se | ||
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-certifier-types-vs | Certifier Types Value Set | active | pher | 2024-10 | us | |
hl7.terminology | R5 | ValueSet/v3-CervicalRoute | CervicalRoute | active | 2014-03 | uv | ||
openehr.base | R5 | ValueSet/character-sets | Character Set | informative | 3 | fhir | 2024-04 | uv |
hl7.terminology | R5 | ValueSet/v3-ActTransportationModeCode | ActTransportationModeCode | active | 2014-03 | uv | ||
hl7.eu.fhir.idea4rc | R4 | ValueSet/chemotherapy-info-eu-i4rc | Chemotherapy Info | draft | 2025-07 | eu | ||
hl7.eu.fhir.idea4rc | R4 | ValueSet/chemo-units-eu-i4rc | Chemotherapy cumulative dose units | draft | 2025-07 | eu | ||
hl7.eu.fhir.pcsp | R4 | ValueSet/ChemoUnitsVs | Chemotherapy cumulative dose units | draft | 2025-08 | eu | ||
hl7.fhir.us.registry-protocols | R4 | ValueSet/ChestPainSymptomAssessment | Chest Pain Symptom Assessment | active | cic | 2023-11 | us | |
hl7.terminology | R5 | ValueSet/v3-Chew | Chew | active | 2014-03 | uv | ||
hl7.fhir.be.pss | R4 | ValueSet/ChlamydiaCodes | Chlamydia Codes | active | 2025-07 | be | ||
hl7.terminology | R5 | ValueSet/v3-GTSAbbreviationHolidaysChristianRoman | GTSAbbreviationHolidaysChristianRoman | active | 2014-03 | uv | ||
hl7.terminology | R5 | ValueSet/chromosome-human | chromosome-human | draft | 1 | cg | 2020-02 | uv |
hl7.fhir.us.registry-protocols | R4 | ValueSet/ChronicLungDisease | Chronic Lung Disease | active | cic | 2023-11 | us | |
hl7.terminology | R5 | ValueSet/citation-artifact-classifier | Citation Artifact Classifier | trial-use | 1 | cds | 2025-01 | uv |
hl7.fhir.uv.extensions.r3 | R3 | ValueSet/citation-artifact-classifier | Citation Artifact Classifier | trial-use | 1 | fhir | 2021-03 | uv |
hl7.terminology | R5 | ValueSet/citation-classification-type | Citation Classification Type | trial-use | 1 | cds | 2025-01 | uv |
hl7.terminology | R5 | ValueSet/cited-artifact-contribution-type | Cited Artifact Contribution Type | trial-use | 1 | cds | 2025-01 | uv |
hl7.terminology | R5 | ValueSet/cited-artifact-classification-type | Cited Artifact Classification Type | trial-use | 1 | cds | 2025-01 | uv |
hl7.terminology | R5 | ValueSet/cited-artifact-status-type | Cited Artifact Status Type | trial-use | 1 | cds | 2025-01 | uv |
hl7.terminology | R5 | ValueSet/v3-RoleClassCitizen | RoleClassCitizen | active | 2014-03 | uv |